New drug aims to stop hip bone death from steroids
NCT ID NCT07471880
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new drug called RAB001 in people with early-stage hip bone damage caused by long-term steroid use. About 160 participants will receive either a low, medium, or high dose of RAB001, or a standard bone drug (alendronate). The goal is to see if RAB001 can reduce the size of the damaged bone area and improve hip function over 48 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- RAB001 (a drug that targets bone repair) and alendronate (Fosamax, a standard bone drug)
- What this could lead to
- If it works, this could point toward a treatment that slows or reverses bone damage in the hip, potentially delaying or avoiding the need for joint replacement.
- What could go wrong
- This is an early Phase 2 trial with only 160 people, so results may not apply to everyone. The drug may not work better than the standard treatment, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEONECROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.
Zhongshan, Guangdong, 528400, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New surgical wash aims to cut joint infection risk in 7,600 replacement patients
- New hip stem could mean better bone preservation for younger patients
- Stem cells and oxygen therapy may save hips from collapse
- Blood test could catch hip disease before It's too late
- New drug RAB001 takes first step: safety check in healthy volunteers
- New combo treatment aims to save hips from collapse